Institutional investors purchased a net $371.3 thousand shares of ORMP during the quarter ended November 2014. This may signal that the smart money is gaining interest in this company as the 9.28% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SEI INVESTMENTS MANAGEMENT CORP. Bought 226.2 Thousand shares of Oramed Pharmaceuticals In...